TCPC:NASDAQBlackRock TCP Capital Corp. Analysis
Data as of 2026-06-20 - not real-time
$3.41
Latest Price
8/10Risk
Risk Level: High
Executive Summary
BlackRock TCP Capital Corp. is trading at $3.41, which sits below its 20‑day SMA of $3.71, 50‑day SMA of $3.99, and 200‑day SMA of $5.02, signaling a bearish price trend. The RSI of 31.8 places the stock in oversold territory, while the MACD line remains under its signal line, reinforcing short‑term downside momentum. Volume is increasing, suggesting heightened trader interest, yet the 30‑day volatility of nearly 40% underscores a highly erratic price environment. The current price hovers just above the computed support level of $3.37 and well beneath the resistance at $3.98, framing a narrow upside window.
Fundamentally, the company posts a staggering 24% dividend yield but a payout ratio of 378%, indicating that the dividend is not sustainable on the backdrop of negative earnings (trailing EPS –$1.49) and a profit margin of –66.9%. Debt is excessive, with a debt‑to‑equity ratio of 164 and a net debt position far outweighing cash on hand. A discounted cash flow model values the firm at roughly $0.87, implying a significant overvaluation relative to the market price, while the fear‑and‑greed index flags “Extreme Greed,” hinting at potential market complacency.
Fundamentally, the company posts a staggering 24% dividend yield but a payout ratio of 378%, indicating that the dividend is not sustainable on the backdrop of negative earnings (trailing EPS –$1.49) and a profit margin of –66.9%. Debt is excessive, with a debt‑to‑equity ratio of 164 and a net debt position far outweighing cash on hand. A discounted cash flow model values the firm at roughly $0.87, implying a significant overvaluation relative to the market price, while the fear‑and‑greed index flags “Extreme Greed,” hinting at potential market complacency.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price below all major moving averages indicating bearish bias
- RSI in oversold region suggests a possible short‑term rebound
- Unsustainable dividend payout ratio raises near‑term earnings concerns
Medium Term
1–3 yearsCautious
Model confidence: 7/10
Key Factors
- DCF fair value of $0.87 versus market price of $3.41 signals a large valuation gap
- Persistent negative earnings and a 57% historic drawdown highlight earnings risk
- High leverage (debt‑to‑equity >160) could pressure cash flow and limit growth
Long Term
> 3 yearsCautious
Model confidence: 8/10
Key Factors
- Structural credit risk from massive debt load and declining revenue
- Negative ROE and weak profit margins indicate long‑term profitability challenges
- Potential dividend cuts or suspensions as earnings remain negative, likely driving price toward fair value
Key Metrics & Analysis
Financial Health
Revenue Growth-23.80%
Profit Margin-66.92%
P/E Ratio4.8
ROE-18.73%
ROA5.91%
Debt/Equity163.83
P/B Ratio0.5
Op. Cash Flow$261.5M
Free Cash Flow$68.8M
Industry P/E16.9
Technical Analysis
TrendBearish
RSI31.8
Support$3.37
Resistance$3.98
MA 20$3.71
MA 50$3.99
MA 200$5.02
MACDBearish
VolumeIncreasing
Fear & Greed Index91.46
Valuation
Fair Value$0.87
Target Price$4.17
Upside/Downside22.19%
GradeOvervalued
TypeValue
Dividend Yield24.14%
Risk Assessment
Beta0.76
Volatility39.58%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.